Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
Clinical trial NCT01754857 · COMPLETED
Trial details
- NCT number
- NCT01754857
- Sponsor
- University of Wisconsin, Madison
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-12
- Primary completion
- 2022-06-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.